Legal Representation
Attorney
Marilyn M. Huston
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 13, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 13, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 20, 2006 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 6, 2006 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 11, 2006 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Apr 11, 2006 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Apr 11, 2006 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Nov 6, 2005 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 6, 2005 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 6, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 6, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 6, 2005 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Dec 6, 2005 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Dec 6, 2005 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Oct 6, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 28, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 15, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 5, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 5, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 6, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 13, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 24, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 12, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 12, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Preparations for clinical or medical laboratory use; pharmaceutical preparations for treatment of ischemia; cardiovascular treatment preparations
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical drug development services; medical and scientific research in the field of gene therapy; development and testing of products for gene therapy and therapeutic angiogenesis; licensing of intellectual property in the fields of gene therapy and therapeutic angiogenesis.
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
DELTA VASCULAR
Classification
International Classes
005
042